Washington, D.C.—In a bipartisan effort to accelerate the prevention, treatment, and cure of neurological diseases, U.S. Senators Susan Collins (R-ME) and Ben Ray Luján (D-NM) introduced the Neuroscience Center of Excellence Act. The legislation would establish a Neuroscience Center of Excellence at the Food and Drug Administration (FDA) and is modeled after the FDA’s successful Oncology Center of Excellence.
The new Neuroscience Center of Excellence will establish several programs aimed at supporting innovative research that will encompass more than 20 neurological diseases, from conditions that are tragically all too common, such as Alzheimer’s disease, to conditions that are very rare, such as Huntington’s disease. These diseases not only exact a human toll, but a financial toll as well. According to researchers at the University of South Florida, the nine most prevalent and costly diagnosed neurological disorders have an annual total cost of nearly $800 billion.
“Neuroscience is an area of medicine where there is tremendous unmet need, and neurodegenerative diseases are particularly challenging from both a research and a drug development perspective,” said Senator Collins. “We desperately need to change the trajectory of neurological diseases and renew our focus on promoting research to find effective means of prevention, treatments, and cures for these debilitating conditions that affect millions of Americans and their families. This legislation Senator Luján and I have introduced would make critical advances for those living with neurological diseases.”
“I’m honored to join Senator Collins to introduce bipartisan legislation to establish a Neuroscience Center of Excellence to address Central Nervous System diseases that impact millions of Americans,” said Senator Luján. “Building on the success of existing Centers of Excellence, this legislation will aid the development of new therapies to better treat Americans.”
The Neuroscience Center of Excellence Act has several components:
Click HERE to read the text of the bill.